• Welcome to the New Conservative Angle!

    We're excited to introduce a new era for our readership.

    For years, Conservative Angle has served as a clearinghouse for news, commentary, and analysis from across the conservative movement. Thousands of readers have visited these pages to stay informed, discover new voices, and keep pace with the stories shaping our nation and our world.

    Today, we are building on that foundation.

    The new Conservative Angle is more than a news aggregator. It is a community.

    Our mission remains the same: to provide access to important stories, encourage informed discussion, and promote the free exchange of ideas. But now, readers have a place to participate, share perspectives, ask questions, and openly and respectfully engage directly with fellow conservatives and independent thinkers.

    As Conservative Angle grows, we will continue adding new features, new content, and new ways for readers to participate. The site will evolve over time based on the interests, ideas, and contributions from the community.

    Whether you are a longtime visitor or discovering Conservative Angle for the first time, we invite you to become part of the conversation.

    Register for an account, introduce yourself to the community, and join the discussions that matter most to you. Together, we can create a place where news is not merely consumed, but examined, debated, and understood.

    Thank you for your patience during our transition and for your continued support.

    Welcome to the new Conservative Angle.

    — The Conservative Angle Team

Breast cancer is too elitist? Muslim Democrat El-Sayed claims the disease affects those with 'social power and privilege'

image.jpg



Cancer research is usually an issue everyone can agree on, but Michigan Senate candidate Abdul El-Sayed begs to differ.

In a resurfaced 2012 essay written by El-Sayed, he questioned the level of federal funding dedicated to breast cancer research and criticized what he called the “pink-ribbon lobby.”

BlazeTV host Sara Gonzales is shocked that the Democrat levied an attack at those trying to research the devastating, and sometimes fatal, disease.

“Cancer sucks,” Gonzales says. “That should be a thing that we can all agree on and all move on with. But unfortunately, there is a Democrat who took the hardline stance that trying to stop people from dying from breast cancer is too elitist for him. He doesn’t support it.”



“He railed against ‘disturbing’ funding for breast cancer research because the disease affects people with quote ‘social power and privilege.’ You couldn’t make this up if you tried,” she explains.

“He denounced the pink-ribbon lobby in an essay published during breast cancer awareness month,” she continues, adding, “So he really, really hates trying to solve and eliminate breast cancer.”

El-Sayed complained that cancer diverts “federal funding away from studying other serious diseases.”

“This so-called ‘pink-ribbon lobby,’ he says, has convinced everyone that they’re going to die from breast cancer,” Gonzales explains.

“Not everyone is going to die,” she continues. “I don’t think they ever said anything like that. But it’s a problem in this country. Can we just agree to that, Abdul? Can we just agree that no one should die from breast cancer? Can we agree that we want less deaths from cancer?”

As for El-Sayed’s absurd claim that the disease affects those with “social power and privilege,” Gonzales likens it to the lockdown measures taken during the COVID pandemic.

“This is like COVID when it could attack you when you were standing up but not when you were sitting down at a restaurant. I guess breast cancer is the same way,” she says, adding, “It only seeks out people with power and privilege.”

Want more from Sara Gonzales?​


To enjoy more of Sara's no-holds-barred takes on news and culture, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.

Continue reading...

[H/T Blaze Media]
  • Reading time 10 min read
  • Reading time 4 min read
  • Views18
  • Reading time 3 min read
  • Views13
  • Reading time 5 min read
  • Views16

Comments

There are no comments to display
Back
Top